Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
NVCR
#1845
NovoCure Limited Ordinary Shares
13.670
0
+2.78%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+2.78%
Variazione Mensile
+4.75%
Variazione di 6 mesi
-0.58%
Variazione Annuale
-0.58%
Chiusura Precedente
13.300
0
Open
13.670
0
Bid
Ask
Low
13.670
0
High
13.670
0
Volume
177
Mercati
Mercato Azionario Statunitense
Salute
NVCR
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
102.41 M
104.42 M
105.46 M
107.09 M
109.92 M
113.79 M
—
Valuation ratios
Enterprise value
17.49 B
7.63 B
7.05 B
1.3 B
3.11 B
1.38 B
6.18 B
Price to earnings ratio
961.33
-134.07
-77.2
-7.38
-19.1
-10.6
-41.83
Price to sales ratio
38.11
14.51
13.22
3.01
5.31
—
—
Price to cash flow ratio
190.02
93.84
230.95
-20.89
-121.87
29.4
-57.48
Price to book ratio
39.54
18.92
16.12
4.23
8.92
4.23
7.93
Enterprise value to EBITDA ratio
465.69
-199.86
-84.8
-5.77
-19.24
—
—
Profitability ratios
Return on assets %
0.02
0.05
0.08
0.18
0.14
0.17
0.12
Return on equity %
0.04
0.14
0.21
0.57
0.47
0.4
0.39
Return on invested capital %
126.89
190.67
412.41
824.83
200.54
132.06
110.67
Gross margin %
78.46
78.53
78.64
74.81
77.33
74.54
298.1
Operating margin %
6.15
8.29
16.64
45.72
28.17
23.47
94.03
EBITDA margin %
7.6
-7.14
-15.46
-44.3
-26.72
-21.48
-79.69
Net margin %
4.01
10.91
17.2
40.65
27.86
20.79
83.76
Liquidity ratios
Quick ratio
8.56
7.36
6.82
5.56
1.42
2.71
7.01
Current ratio
8.8
7.53
7
5.78
1.46
2.9
7.35
Inventory turnover
0.02
0.04
0.01
0
0.01
0.08
—
Asset turnover
0.65
0.49
0.46
0.44
0.51
0.64
0.54
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.41
0.49
0.47
0.5
0.08
0.24
0.54
Long term debt to total equity ratio
0.9
1.37
1.28
1.57
0.27
0.57
1.69
Per share metrics
Operating cash flow per share
0.91
0.8
0.29
0.69
0.24
0.44
0.44
EBIT per share
0.28
-0.43
-0.86
-2.19
-1.58
-1.38
-1.38
EBITDA per share
0.34
-0.37
-0.79
-2.12
-1.5
-1.26
-1.17
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.74
9.07
9.26
8.56
8.9
4.02
29.85
Net current asset value per share
9.18
10.38
10.62
9.72
10.26
5.8
36.11
Tangible book value per share
4.38
3.97
4.22
3.41
3.34
3.05
12.52
Working capital per share
8.14
9
9.1
8.04
3.25
3.8
13.71
Book value per share
4.38
3.97
4.22
3.41
3.34
3.05
12.52
Notizie
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript
Gli EPS di Novocure Ltd hanno battuto le aspettative per 0,19$, il fatturato supera le previsioni
Novocure Ltd earnings beat by $0.19, revenue topped estimates
Netflix and Palantir among market cap stock movers on Wednesday
Novocure earnings up next: Pancreatic cancer launch in focus
Oracle and Netflix among market cap stock movers on Wednesday
Le azioni Novocure balzano dopo il ripristino della fatturazione Medicare
Novocure stock jumps after Medicare billing restored
Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching